knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 13:05:11 - browse：342

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

WSS

Inside the rise of 'mukbang' eating videos

Can medical device makers keep up in the race to treat obesity?

Biden administration plans revamp of organ transplant system

OTC birth control: A brief history of over the counter pill design

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Senate panel passes drug pricing bills, but drops one PBM reform

focus

knowledge

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Millions may soon lose Medicaid when they don't have to

Drug repurposing or repositioning? The language matters

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Can medical device makers keep up in the race to treat obesity?

ChatGPT in medicine: STAT answers readers' burning questions

The drug industry sees a key ally in the Senate prevail

Wildfire smoke exposes gaps in outdoor worker protections

Nearly two

explore

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

What Mike Pence has said that could be used in a Donald Trump trial

'Ancient DNA,' 23andMe reveal African American ancestries

Microsoft strikes partnership with Duke Health to advance health AI

Millions may soon lose Medicaid when they don't have to

focus

focus

leisure time

Wikipedia